Spencer Kobren Interviews Replicel's CEO Concerning Latest Clinical Trial Results

[Follicle Death Row]

Intercytex phase 1: "Although it is too early to determine fully the differences between the sub-groups, the preliminary data are encouraging. In the first sub-group 2 patients out of 5 showed substantial increases in hair count (21 & 55%) at 24 weeks. In the second sub-group (5 patients in total) injected more recently, all patients showed substantial and visible increased hair counts at 6 and/or 12 weeks (13-105%). We believe this increased hair production is attributable to the interaction between the injected DP cells and the stimulated resident hair producing cells."

Intercytex release results that clearly beat that of Replicel - but where are they now? People are telling me Replicel have a better chance with worse results? lmfao.

Aderans own that intellectual property now I think. We hardly ever mention Aderans because of the Bosley connection but seems like they're going to wrap up phase 2 late this year or early next year. They're miles ahead of the chasing pack and have massive money behind them.

[UK_]

Aderans own that intellectual property now I think. We hardly ever mention Aderans because of the Bosley connection but seems like they're going to wrap up phase 2 late this year or early next year. They're miles ahead of the chasing pack and have massive money behind them.

We dont mention Aderans because:

https://www.youtube.com/watch?v=C7SwA1ENqxI